2587 — HealthyWay Income Statement
0.000.00%
Last trade - 00:00- HK$27.87bn
- HK$27.78bn
- CNY1.20bn
Annual income statement for HealthyWay, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PRESS |
| Standards: | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 431 | 569 | 1,244 | 1,201 |
| Cost of Revenue | ||||
| Gross Profit | 173 | 246 | 398 | 366 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Unusual Expense / Income | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 498 | 558 | 1,237 | 1,187 |
| Operating Profit | -66.4 | 10.9 | 7.16 | 13.7 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -152 | -258 | -321 | -264 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -155 | -256 | -314 | -269 |
| Minority Interest | ||||
| Net Income Before Extraordinary Items | ||||
| Net Income | -157 | -258 | -310 | -268 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -157 | -258 | -310 | -268 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.184 | -0.309 | -0.375 | -0.306 |